Ivosidenib + Mao Inhibitors Interaction
Majorinteraction on record
Description
Co-administration increases ivosidenib plasma concentrations and may increase risk of QTc interval prolongation. Reduce TIBSOVO dose to 250 mg once daily if unavoidable.
Mechanism
CYP3A4 inhibition increases ivosidenib exposure
Source: NLP:ivosidenib